Search results
Roche (RHHBY), Ascidian Team Up for RNA Exon Editing Therapeutics
Zacks via Yahoo Finance· 11 hours agoRoche (RHHBY) gets exclusive, target-specific rights to Ascidian's RNA exon editing technology for...
Ascidian and Roche to develop RNA therapies for neurological diseases
Pharmaceutical Technology via Yahoo Finance· 20 hours agoAscidian Therapeutics has entered a research partnership and licensing agreement with Roche to...
Roche partners with Ascidian Therapeutics to develop gene therapies
Reuters· 1 day ago, opens new tab will team up with privately held biotech Ascidian Therapeutics to develop gene...
Police presence, gunfire reported near Milwaukee's Washington Park
WISN 12 Milwaukee· 2 hours agoTHE SCENE IS UNFOLDING RIGHT NOW ON THE NORTH SIDE OF WASHINGTON PARK. TONIGHT, 12 NEWS ERICA FINK...
One of Philadelphia's leading real estate teams rebrands, looks to expand - Philadelphia Business...
The Business Journals· 3 hours agoOne of Philadelphia's largest real estate teams by volume has rebranded with an eye toward growth...
Georgia Tech Receives Commitment From Massive 2025 Tight End Kevin Roche
Sports Illustrated· 2 days agoRoche is a huge prospect with 6'8 235 LBS size and has been underlooked in the recruiting process so...
Roche gains 501(k) clearance for digital pathology solution for diagnostic use
Medical Device Network via Yahoo Finance· 2 days agoRoche’s Digital Pathology Dx system is intended to aid pathologists in reviewing and interpreting...
In Ukraine, ‘We Know Why We Fight’
The Dispatch via Yahoo News· 22 hours agoCommander Viatcheslav of the 247th Kharkiv Territorial Defense Brigade. (Photo by Joseph Roche.) KHARKIV OBLAST, Ukraine—An old green Soviet Lada,...
TE Kevin Roche commits to Georgia Tech on his OV
Jackets Online· 2 days agoRoche gives Tech a second TE commit for the 2025 class Russell Johnson Darien (CT) tight end Kevin Roche made the most of his Georgia Tech official visit...
Roche partners with RNA editing biotech Ascidian
BioPharma Dive via Yahoo Finance· 2 days agoWhile the Swiss pharma recently pruned its neurology drug pipeline, it has shown interest in the possibilities of RNA-focused approaches like what...
